Supraphysiologic Testosterone Solutions for Enzalutamide-resistant Prostate Cancer

被引：5
|
作者：
Thomas, Lewis [1 ,2 ]
Baratchian, Mehdi [1 ]
Sharifi, Nima [1 ,2 ,3 ]
机构：
[1] Cleveland Clin, Lerner Res Inst, Genitourinary Malignancies Res Ctr, Cleveland, OH 44106 USA
[2] Cleveland Clin, Dept Urol, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA
[3] Cleveland Clin, Dept Hematol & Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA
来源：
EUROPEAN UROLOGY | 2020年 / 77卷 / 02期
关键词：
D O I：
10.1016/j.eururo.2019.07.037
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：156 / 157
页数：2
相关论文
共 50 条
  • [1] Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
    Tucci, Marcello
    Zichi, Clizia
    Buttigliero, Consuelo
    Vignani, Francesca
    Scagliotti, Giorgio V.
    Di Maio, Massimo
    ONCOTARGETS AND THERAPY, 2018, 11 : 7353 - 7368
  • [2] MCT INHIBITION RESENSITIZES ENZALUTAMIDE-RESISTANT PROSTATE CANCER CELLS TO ENZALUTAMIDE
    Bhattacharjee, Sayani
    Wynn, Rebecca
    Sindhwani, Puneet
    Petros, Firas
    Nadiminty, Nagalakshmi
    JOURNAL OF UROLOGY, 2023, 209 : E146 - E146
  • [3] Critical role of antioxidant programs in enzalutamide-resistant prostate cancer
    Eliot B. Blatt
    Karla Parra
    Antje Neeb
    Lorenzo Buroni
    Denisa Bogdan
    Wei Yuan
    Yunpeng Gao
    Collin Gilbreath
    Alec Paschalis
    Suzanne Carreira
    Ralph J. DeBerardinis
    Ram S. Mani
    Johann S. de Bono
    Ganesh V. Raj
    Oncogene, 2023, 42 : 2347 - 2359
  • [4] DO EXOSOMES CONTRIBUTE TO THE DEVELOPMENT OF ENZALUTAMIDE-RESISTANT PROSTATE CANCER?
    Peak, Taylor
    Panigrahi, Gati
    Praharaj, Prakash
    Chavez, Jose
    Chyr, Jacqueline
    Singh, Ravi
    Griend, Donald Vander
    Bitting, Rhonda
    Hemal, Ashok
    Deep, Gagan
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1224 - E1224
  • [5] Critical role of antioxidant programs in enzalutamide-resistant prostate cancer
    Blatt, Eliot B.
    Parra, Karla
    Neeb, Antje
    Buroni, Lorenzo
    Bogdan, Denisa
    Yuan, Wei
    Gao, Yunpeng
    Gilbreath, Collin
    Paschalis, Alec
    Carreira, Suzanne
    DeBerardinis, Ralph J.
    Mani, Ram S.
    de Bono, Johann S.
    Raj, Ganesh V.
    ONCOGENE, 2023, 42 (30) : 2347 - 2359
  • [6] Pathways to enzalutamide resistance: An analysis of proteomic changes in enzalutamide-resistant prostate cancer cells
    Molokwu, Chidi N.
    Kristensen, Anders
    Sutton, Chris
    CANCER RESEARCH, 2024, 84 (03)
  • [7] AMINO ACID TRANSPORT INHIBITION RESENSITIZES ENZALUTAMIDE-RESISTANT PROSTATE CANCER CELLS TO ENZALUTAMIDE
    Seyan, Zheyar J.
    Wolpert, John
    Stroever, Stephanie
    de Riese, Werner T. W.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E49 - E49
  • [8] Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer
    Bengul Gokbayrak
    Umut Berkay Altintas
    Shreyas Lingadahalli
    Tunc Morova
    Chia-Chi Flora Huang
    Betul Ersoy Fazlioglu
    Ivan Pak Lok Yu
    Batuhan M. Kalkan
    Paloma Cejas
    Sonia H. Y. Kung
    Ladan Fazli
    Akane Kawamura
    Henry W. Long
    Ceyda Acilan
    Tamer T. Onder
    Tugba Bagci-Onder
    James T. Lynch
    Nathan A. Lack
    Communications Biology, 8 (1)
  • [9] Neuropilin-2 promotes enzalutamide-resistant neuroendocrine prostate cancer
    Wang, Jing
    Li, Jingjing
    Wu, Boyang
    Yin, Lijuan
    CANCER RESEARCH, 2020, 80 (16)
  • [10] Aryl hydrocarbon receptor is critical for enzalutamide-resistant prostate cancer growth
    Chen, Chia-Hui
    Wu, Boyang Jason
    CANCER RESEARCH, 2023, 84 (06)
12345